Literature DB >> 14500084

Clinical results of thoracoscopic Heller's myotomy in the treatment of achalasia.

M Codispoti1, S Y Soon, G Pugh, W S Walker.   

Abstract

OBJECTIVES: Ideal treatment for achalasia permanently eliminates the dysfunctional lower oesophageal sphincter, relieving dysphagia and regurgitation. The aim of this study was to review the results in a series of patients undergoing video-imaged thoracoscopic Heller's myotomy (THM).
METHODS: Records of all patients undergoing THM by a single surgeon at one institution were analysed. Follow-up was conducted using a structured questionnaire together with oesophageal manometry and/or 24 h pH monitoring when clinically indicated.
RESULTS: Twenty-five consecutive patients (13 males, 12 females, mean age 40.3+/-19.9 years) suffering from grade 4 dysphagia underwent THM between 1993 and 2001. Preoperative mean lower oesophageal sphincter (LOS) pressure was 42.6+/-6.3 mmHg. Seven patients (28%) had undergone previous pneumatic dilatations. There were no hospital deaths and no oesophageal perforations. Length of hospital stay was 4.3+/-1.8 days. One patient died 3 years after surgery from unrelated causes. At follow-up of 5.4+/-2.1 years, freedom from any reintervention was 95.8% (23/24). Eleven patients (45.8%) were asymptomatic. In patients with residual or recurrent symptoms (n=13), their severity was significantly reduced from the preoperative period (dysphagia score 1.7+/-0.8 versus 4+/-0; P</=0.05). Four patients (16%) with troublesome residual or recurrent grade 3-4 dysphagia underwent repeat oesophageal manometric study, showing a mean reduction in LOS pressure from their baseline values of 46.8+/-6.1 to 30+/-5.4 mmHg (P</=0.01). One of these patients (4.2%) required repeat Heller's myotomy 1.5 years after THM. Six patients complained of troublesome postoperative heartburn; distal oesophageal acid exposure was shown to be abnormal in 3 (12.5%) of these patients and all enjoyed symptomatic relief with medical therapy.
CONCLUSIONS: THM is a safe and effective procedure in the treatment of achalasia. Some patients do experience recurrence of symptoms; however, these are significantly less severe. The incidence of postoperative heartburn is acceptably low and can be controlled with oral medications, making the addition of an anti-reflux procedure not necessary. Longer-term follow up and randomised studies comparing THM to other therapeutic modalities are needed to ascertain respectively the durability of this approach and its relative advantages.

Entities:  

Mesh:

Year:  2003        PMID: 14500084     DOI: 10.1016/s1010-7940(03)00432-9

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  7 in total

1.  Esophagectomy for end stage achalasia.

Authors:  Stephen M Glatz; J David Richardson
Journal:  J Gastrointest Surg       Date:  2007-07-11       Impact factor: 3.452

2.  Minimally invasive surgery for esophageal achalasia.

Authors:  Huan-Wen Chen; Ming Du
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

3.  A total fundoplication is not an obstacle to esophageal emptying after heller myotomy for achalasia: results of a long-term follow up.

Authors:  Gianluca Rossetti; Luigi Brusciano; Giuseppe Amato; Vincenzo Maffettone; Vincenzo Napolitano; Gianluca Russo; Domenico Izzo; Federica Russo; Francesco Pizza; Gianmattia Del Genio; Alberto Del Genio
Journal:  Ann Surg       Date:  2005-04       Impact factor: 12.969

4.  Revisional surgery after heller myotomy for treatment of achalasia: a comparative analysis focusing on operative approach.

Authors:  Biswanath P Gouda; Thomas Nelson; Sunil Bhoyrul
Journal:  Indian J Surg       Date:  2012-01-21       Impact factor: 0.656

5.  The cost of laparoscopic myotomy versus pneumatic dilatation for esophageal achalasia.

Authors:  Paul J Karanicolas; Shona E Smith; Richard I Inculet; Richard A Malthaner; Richard P Reynolds; Ron Goeree; Amiram Gafni
Journal:  Surg Endosc       Date:  2007-05-04       Impact factor: 4.584

Review 6.  A controversy that has been tough to swallow: is the treatment of achalasia now digested?

Authors:  Garrett R Roll; Charlotte Rabl; Ruxandra Ciovica; Sofia Peeva; Guilherme M Campos
Journal:  J Gastrointest Surg       Date:  2009-09-17       Impact factor: 3.452

7.  Minimally invasive management of achalasia cardia: results from a single center study.

Authors:  C Palanivelu; G S Maheshkumar; Kalpesh Jani; R Parthasarthi; K Sendhilkumar; M Rangarajan
Journal:  JSLS       Date:  2007 Jul-Sep       Impact factor: 2.172

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.